AI assistant
Hester Biosciences Ltd — Call Transcript 2022
May 14, 2022
62222_rns_2022-05-14_3c9b137d-d357-4eb0-bef7-790949786136.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [595 x 128] intentionally omitted <==
14 May 2022
To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 524669
To, National Stock Exchange of India Limited Exchange Plaza, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051
Symbol: HESTERBIO
Respected Sir/ Madam:
Subject: Intimation of earnings conference call
This is to inform you that as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has arranged earnings conference call on Friday, 20 May 2022 at 2:00 p.m. (IST) to discuss the Standalone and Consolidated Audited Financial Results for the quarter and year ended 31 March 2022.
You are requested to take the above on record.
Sincerely For Hester Biosciences Limited
==> picture [77 x 38] intentionally omitted <==
Vinod Mali Company Secretary & Compliance Officer
==> picture [198 x 32] intentionally omitted <==
is pleased to invite you to the
Q4 & FY22 Results Conference Call
of
==> picture [73 x 73] intentionally omitted <==
Hester Biosciences Limited
Represented by \
Mr. Rajiv Gandhi, CEO & Managing Director Ms. Priya Gandhi, Executive Director Mr. Nikhil Jhanwar, Chief Financial Officer
on
Friday, May 20, 2022 at 14:00 hrs India Time
Diamond Pass registration link: Copy this Link in your browser: Link
Call Co-ordinator:
Mr. Vinay Bafna: Phone: +91 22 6807 7339, e-mail: [email protected] Mr. Mitesh Shah: Phone: +91 22 6807 7452, e-mail: [email protected] For any clarification, please contact:
Mr. Rushad Kapadia: Phone: +91 22 6807 7334, e-mail: [email protected] Ms. Divya Purohit: Phone: +91 22 6807 7454, e-mail: [email protected] Ms. Seema Sehgal: Phone: +91 11 4221 8511, e-mail: [email protected]